3.74
price up icon7.16%   0.25
after-market Handel nachbörslich: 3.81 0.07 +1.87%
loading

Atea Pharmaceuticals Inc Aktie (AVIR) Neueste Nachrichten

pulisher
Jul 23, 2025

What drives Atea Pharmaceuticals Inc. stock priceUnprecedented profit potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Atea Pharmaceuticals Inc. stockFree High-Return Strategy Alerts - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Atea Pharmaceuticals Insiders Placed Bullish Bets Worth US$5.40m - Yahoo.co

Jul 23, 2025
pulisher
Jul 23, 2025

Atea Pharmaceuticals Inc. Stock Analysis and ForecastDynamic investment growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Atea Pharmaceuticals Inc. a good long term investmentFree Investment Community - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 15, 2025

Why Atea Pharmaceuticals Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Atea Pharmaceuticals Inc. stock price move sharplyFree Stock Portfolio Optimization - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Atea Pharmaceuticals Inc. stock performs during market volatilityFree Stock Movement Tracking - Newser

Jul 15, 2025
pulisher
Jun 29, 2025

Atea Pharmaceuticals announces continued advancement of global Phase 3 HCV program - European AIDS Treatment Group

Jun 29, 2025
pulisher
Jun 26, 2025

Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing - Bain Capital

Jun 26, 2025
pulisher
Jun 24, 2025

New Hepatitis C Treatment Could Slash Therapy Time to 8 Weeks as Global Phase 3 Trial Advances - Stock Titan

Jun 24, 2025
pulisher
Jun 20, 2025

Atea Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 20, 2025
pulisher
Jun 17, 2025

Here's Why We're Not At All Concerned With Atea Pharmaceuticals' (NASDAQ:AVIR) Cash Burn Situation - Yahoo Finance

Jun 17, 2025
pulisher
Jun 15, 2025

Bank of America Corp DE Boosts Stock Position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Invests $75,000 in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 14, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Buys 35,053 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Shares Sold by Two Sigma Investments LP - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Jane Street Group LLC Decreases Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Public Employees Retirement System of Ohio Trims Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Ameriprise Financial Inc. Sells 11,900 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

ProShare Advisors LLC Buys 6,163 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace

Jun 02, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Buys New Shares in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

May 27, 2025
pulisher
May 26, 2025

Northern Trust Corp Boosts Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

May 26, 2025
pulisher
May 24, 2025

D. E. Shaw & Co. Inc. Purchases 62,505 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

May 24, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades Atea Pharmaceuticals (NASDAQ:AVIR) to “Hold” - Defense World

May 24, 2025
pulisher
May 17, 2025

Price T Rowe Associates Inc. MD Purchases 3,882 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

May 17, 2025
pulisher
May 16, 2025

Q2 EPS Forecast for Atea Pharmaceuticals Reduced by Analyst - Defense World

May 16, 2025
pulisher
May 14, 2025

Dimensional Fund Advisors LP Has $3.27 Million Stake in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

May 14, 2025
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):